Unichem Laboratories Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹632.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.00 per cent from ₹575.12 crore. This corresponds to a year-on-year *(YoY) growth of 20.13 per cent.
Operating Profit
Operating Profit stands at ₹69.94 crore, reflecting a quarter-on-quarter *(QoQ) increase of 98.02 per cent from ₹35.32 crore. This corresponds to a year-on-year *(YoY) growth of 210.98 per cent.
PBDT
PBDT stands at ₹78.93 crore, reflecting a quarter-on-quarter *(QoQ) increase of 59.78 per cent from ₹49.40 crore. This corresponds to a year-on-year *(YoY) growth of 246.64 per cent.
Profit Before Tax
Profit Before Tax stands at ₹48.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 160.72 per cent from ₹18.79 crore. This corresponds to a year-on-year *(YoY) growth of 643.13 per cent.
Net Profit
Net Profit stands at ₹41.47 crore, reflecting a quarter-on-quarter *(QoQ) increase of 280.11 per cent from ₹10.91 crore. This represents a 496.08 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Unichem Laboratories Ltd News
Unichem Laboratories Ltd Earnings
- YOY
- QOQ
Unichem Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Unichem Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Unichem Laboratories Ltd Financial Reports
Unichem Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Unichem Labs. | -2.51% | -6.24% | -12.13% | -13.16% | 25.19% | -0.03% |
| SMS Pharma. | -3.08% | -4.75% | -10.19% | 6.06% | 3.46% | 38.44% |
| Kwality Pharma | -2.48% | 5.22% | -1.36% | 30.17% | 121.06% | 290.26% |
| Aarti Drugs | -1.86% | -6.28% | -12.83% | -9.01% | -1.93% | -23.82% |
| Solara Active | -1.89% | -5.44% | -16.96% | 21.08% | 26.50% | 3.64% |
| Shukra Pharma. | 3.34% | -5.96% | 8.72% | 103.66% | 107.52% | 57.24% |
| Ind-Swift Labs. | -5.05% | -6.98% | -19.72% | 36.73% | 143.45% | 213.23% |
Company Info
Company Information
Chairman(Non Exe)&Dir(Non-Ind) : Prakash A Mody
Managing Director & CEO : Pabitra Bhattacharya
Non-Exec & Non-Independent Dir : Pranay Godha
Independent Non Exe. Director : Anand T Kusre
Independent Non Exe. Director : Arun Todarwal
Independent Non Exe. Director : Swati Patankar
HEAD - LEGAL / CS / CHIEF COMPLIANCE OFFICER : Pradeep Bhandari